1. Home
  2. BHVN vs NNI Comparison

BHVN vs NNI Comparison

Compare BHVN & NNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BHVN
  • NNI
  • Stock Information
  • Founded
  • BHVN 2013
  • NNI 1978
  • Country
  • BHVN United States
  • NNI United States
  • Employees
  • BHVN N/A
  • NNI N/A
  • Industry
  • BHVN Biotechnology: Pharmaceutical Preparations
  • NNI Finance: Consumer Services
  • Sector
  • BHVN Health Care
  • NNI Finance
  • Exchange
  • BHVN Nasdaq
  • NNI Nasdaq
  • Market Cap
  • BHVN 3.6B
  • NNI 4.0B
  • IPO Year
  • BHVN 2017
  • NNI 2003
  • Fundamental
  • Price
  • BHVN $36.17
  • NNI $106.67
  • Analyst Decision
  • BHVN Strong Buy
  • NNI Hold
  • Analyst Count
  • BHVN 13
  • NNI 1
  • Target Price
  • BHVN $63.00
  • NNI $98.00
  • AVG Volume (30 Days)
  • BHVN 1.1M
  • NNI 58.5K
  • Earning Date
  • BHVN 11-12-2024
  • NNI 11-07-2024
  • Dividend Yield
  • BHVN N/A
  • NNI 1.06%
  • EPS Growth
  • BHVN N/A
  • NNI N/A
  • EPS
  • BHVN N/A
  • NNI 3.11
  • Revenue
  • BHVN N/A
  • NNI $1,260,967,000.00
  • Revenue This Year
  • BHVN N/A
  • NNI N/A
  • Revenue Next Year
  • BHVN $197.10
  • NNI $5.55
  • P/E Ratio
  • BHVN N/A
  • NNI $34.03
  • Revenue Growth
  • BHVN N/A
  • NNI 3.60
  • 52 Week Low
  • BHVN $26.80
  • NNI $82.22
  • 52 Week High
  • BHVN $62.21
  • NNI $127.32
  • Technical
  • Relative Strength Index (RSI)
  • BHVN 33.02
  • NNI 41.21
  • Support Level
  • BHVN $36.70
  • NNI $104.31
  • Resistance Level
  • BHVN $42.13
  • NNI $109.70
  • Average True Range (ATR)
  • BHVN 2.84
  • NNI 2.18
  • MACD
  • BHVN -0.67
  • NNI -0.14
  • Stochastic Oscillator
  • BHVN 13.18
  • NNI 24.29

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. Its products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

About NNI Nelnet Inc.

Nelnet Inc is a United States based company engaged in these four segments; Loan Servicing and Systems focuses on student and consumer loan origination services and servicing, loan origination and servicing-related technology solutions, and outsourcing business services; Education Technology, Services, and Payment Processing provides education services, payment technology, and community management solutions for K-12 schools, institutions, churches, and businesses; Asset Generation and Management Includes the acquisition and management of student and other loan assets; and Nelnet Bank focuses on the private education and unsecured consumer loan markets. Loan Servicing and Systems Segment derives majority of the company's revenue.

Share on Social Networks: